Dr. He is recognized internationally for three discoveries that include pioneering the use of chromatin dynamics to predict transcription factor binding, elucidating the roles of noncoding RNAs in cancer biology and illuminating epigenetic vulnerabilities in cancer cells. Dr. He has authored over 70 publications at high profile journals including Cell (2018, 2019), Nature Genetics (2016, 2020) and Nature Cell Biology (2020). The translational research in Dr. He’s laboratory has resulted in one phase II clinical trial and two patents. Dr. He has received many distinctions and recognitions, including a number of new investigator awards from national funding agencies, as well as being named a rising star in prostate cancer research.